A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants
Clinical trial NCT05896683 · COMPLETED
Trial details
- NCT number
- NCT05896683
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-30
- Primary completion
- 2023-09-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.